What does CUSIP 53220K954 represent in this 13F holders report?

CUSIP 53220K954 is the security identifier for 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put used to aggregate holder disclosures.

How many institutions held 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put in Q2 2023?

No institutional holders were reported for 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put in Q2 2023; review adjacent reporting periods for trend context.

LIGAND PHARMACEUTICALS INC - COM NEW - Put

CUSIP: 53220K954

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / COM NEW
Price per share: $71.76
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 53220K954?
CUSIP 53220K954 identifies 53220K954 - LIGAND PHARMACEUTICALS INC - COM NEW - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 53220K954:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

LIGAND PHARMACEUTICALS INC - COM NEW - Put

Q2 2023 13F Holders as of 30 Jun 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of LIGAND PHARMACEUTICALS INC - COM NEW - Put as of Q2 2023.